Article

A review: Possible optimization of Cas9-sgRNA nuclease delivery via ingested lipid nanoparticles bioencapsulated within plant cell-based enfolding

2019-06-07

Abstract excerpt

The possibility of gene editing to correct disorders is one of the most impactful therapeutic agents, currently. CRISPR Cas9-sgRNA nucleases can be used to cleave and to delete harmful or pathogenic DNA sequences, which cause genetic disorders. Cas9 nuclease with palindromic repeats can cut and delete a single point mutation or multiple DNA target site sequences. The Cas9, attached to a sgRNA or a guiding RNA, fin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fabe3105-dceb-57de-aa7e-a98f642e96d0
DOI: 10.7287/peerj.preprints.27709v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A review: Possible optimization of Cas9-sgRNA nuclease delivery via ingested lipid nanoparticles bioencapsulated within plant cell-based enfoldingDOI 10.7287/peerj.preprints.27709v2Read

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug deliverySemantic proximity Read

The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cellsSemantic proximity Read

Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9Semantic proximity Read

New frontiers in CRISPR/Cas9 delivery systems delivery for gene editingSemantic proximity Read

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome EditingSemantic proximity Read

Impact of Formulation Conditions on Lipid Nanoparticle Characteristics and Functional Delivery of CRISPR RNP for Gene Knock-Out and CorrectionSemantic proximity Read

Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical TargetsSemantic proximity Read

Bridging Nature and Nanotechnology: Harnessing Plant-Derived Exosome-Like Nanoparticles for Targeted Therapy in Inflammatory DiseasesSemantic proximity Read

Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoproteinSemantic proximity Read

CRISPR delivery particles for developing therapeutic strategies in metabolic diseaseSemantic proximity Read

Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-viral Extracellular NanoparticlesSemantic proximity Read

CRISPR delivery with extracellular vesicles: Promises and challengesSemantic proximity Read